K2 Principal Fund L.P. acquired a new stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund acquired 195,292 shares of the company's stock, valued at approximately $1,945,000. K2 Principal Fund L.P. owned approximately 0.87% of Oaktree Acquisition Corp. III Life Sciences at the end of the most recent quarter.
Separately, AQR Arbitrage LLC bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at about $19,743,000.
Oaktree Acquisition Corp. III Life Sciences Stock Performance
NASDAQ:OACC traded down $0.01 during midday trading on Friday, hitting $10.45. The company had a trading volume of 2,925 shares, compared to its average volume of 95,922. Oaktree Acquisition Corp. III Life Sciences has a 52-week low of $9.95 and a 52-week high of $10.85. The stock has a fifty day simple moving average of $10.23.
About Oaktree Acquisition Corp. III Life Sciences
(
Free Report)
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.
Featured Stories
Before you consider Oaktree Acquisition Corp. III Life Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oaktree Acquisition Corp. III Life Sciences wasn't on the list.
While Oaktree Acquisition Corp. III Life Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
